APA

James N. D., Sydes M. R., Clarke N. W., Ritchie A. W. S. & Parmar M. K. B. (20180813). Response to 'High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice', by Tanguay et al. : Clinical oncology (Royal College of Radiologists (Great Britain)).

Chicago

James N D, Sydes M R, Clarke N W, Ritchie A W S and Parmar M K B. 20180813. Response to 'High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice', by Tanguay et al. : Clinical oncology (Royal College of Radiologists (Great Britain)).

Harvard

James N. D., Sydes M. R., Clarke N. W., Ritchie A. W. S. and Parmar M. K. B. (20180813). Response to 'High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice', by Tanguay et al. : Clinical oncology (Royal College of Radiologists (Great Britain)).

MLA

James N D, Sydes M R, Clarke N W, Ritchie A W S and Parmar M K B. Response to 'High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice', by Tanguay et al. : Clinical oncology (Royal College of Radiologists (Great Britain)). 20180813.